［1］ Lin Z,Liu S,Xu J,et al.A new molecular mechanism underlying the EGCG-mediated autophagic modulation of AFP in HepG2 cells［J］.Cell Death & Disease,2017,8(11):e3160.
[2] Li W,Zhu S,Li J,et al.EGCG stimulates autophagy and reduces cytoplasmic HMGB1 levels in endotoxin-stimulated macrophages［J］.Biochemical Pharmacology,2011,81(9):1152-1163.
[3] Huang CY,Chiang SF,Ke TW,et al.Cytosolic high-mobility group box protein 1 (HMGB1) and/or PD-1+TILs in the tumor microenvironment may be contributing prognostic biomarkers for patients with locally advanced rectal cancer who have undergone neoadjuvant chemoradiotherapy［J］.Cancer Immunology Immunotherapy,2018,67(4):551-562.
[4] Xiao Y,Sun L,Fu Y,et al.High mobility group box 1 promotes sorafenib resistance in HepG2 cells and in vivo［J］.Bmc Cancer,2017,17(1):857.
[5] Tsai CY,Chen CY,Chiou YH,et al.Epigallocatechin-3-gallate suppresses human herpesvirus 8 replication and induces ROS leading to apoptosis and autophagy in primary effusion lymphoma cells［J］.International Journal of Molecular Sciences,2017,19(1):16.
[6] Holczer M,Besze B,Zámbó V,et al.Epigallocatechin-3-gallate (EGCG) promotes autophagy-dependent survival via influencing the balance of mTOR-AMPK pathways upon endoplasmic reticulum stress［J］.Oxidative Medicine & Cellular Longevity,2018,2018:6721530.
[7] Wang W,Chen D,Zhu K.SOX2OT variant 7 contributes to the synergistic interaction between EGCG and Doxorubicin to kill osteosarcoma via autophagy and stemness inhibition［J］.Journal of Experimental & Clinical Cancer Research,2018,37(1):37.
[8] Li S,Xia Y,Chen K,et al.Epigallocatechin-3-gallate attenuates apoptosis and autophagy in concanavalin A-induced hepatitis by inhibiting BNIP3［J］.Drug Design Development & Therapy,2016,10(1):631-647.
[9] Chen Y,Huang L,Zhang H,et al.Reduction in autophagy by (-)-epigallocatechin-3-gallate (EGCG):A potential mechanism of prevention of mitochondrial dysfunction after subarachnoid hemorrhage［J］.Molecular Neurobiology,2017,54(1):392-405.
[10] Huang J,Chen S,Shi Y,et al.Epigallocatechin gallate from green tea exhibits potent anticancer effects in A-549 non-small lung cancer cells by inducing apoptosis,cell cycle arrest and inhibition of cell migration［J］.Journal of Buon,2017,22(6):1422-1427.
[11] Chakrabarty S,Ganguli A,Das A,et al.Epigallocatechin-3-gallate shows anti-proliferative activity in HeLa cells targeting tubulin-microtubule equilibrium［J］.Chemico-Biological Interactions,2015,242:380-389.
[12] Yang C,Du W,Yang D.Inhibition of green tea polyphenol EGCG［(-)-epigallocatechin-3-gallate］ on the proliferation of gastric cancer cells by suppressing canonical wnt/β-catenin signalling pathway［J］.International Journal of Food Sciences & Nutrition,2016,67(7):818-827.
[13] Valenti D,De BL,Manente GA,et al.Negative modulation of mitochondrial oxidative phosphorylation by epigallocatechin-3 gallate leads to growth arrest and apoptosis in human malignant pleural mesothelioma cells［J］.Biochim Biophys Acta,2013,1832(12):2085-2096.
[14] Mayr C,Wagner A,Neureiter D,et al.The green tea catechin epigallocatechin gallate induces cell cycle arrest and shows potential synergism with cisplatin in biliary tract cancer cells［J］.Bmc Complementary & Alternative Medicine,2015,15(1):1-7.
[15] Tang P,Sun Q,Yang H,et al.Honokiol nanoparticles based on epigallocatechin gallate functionalized chitin to enhance therapeutic effects against liver cancer［J］.Int J Pharm,2018,45(1-2):74-83.
[16] Liu S,Xu ZL,Sun L,et al.Epigallocatechin-3-gallate induces apoptosis in human pancreatic cancer cells via PTEN［J］.Molecular Medicine Reports,2016,14(1):599-605.
[17] Meng J,Tong Q,Liu X,et al.Epigallocatechin-3-gallate inhibits growth and induces apoptosis in esophageal cancer cells through the demethylation and reactivation of the p16 gene［J］.Oncology Letters,2017,14(1):1152.
[18] Liu L,Zuo J,Wang G.Epigallocatechin-3-gallate suppresses cell proliferation and promotes apoptosis in Ec9706 and Eca109 esophageal carcinoma cells［J］.Oncology Letters,2017,14(4):4391.
[19] Liu L,Ju Y,Wang J,et al.Epigallocatechin-3-gallate promotes apoptosis and reversal of multidrug resistance in esophageal cancer cells［J］.Pathol Res Pract,2017,213(10):1242-1250.
[20] Feng C,Ho Y,Sun C,et al.Epigallocatechin gallate inhibits the growth and promotes the apoptosis of bladder cancer cells［J］.Experimental & Therapeutic Medicine,2017,14(4):3513.
[21] Wang J,Zhu C,Song D,et al.Epigallocatechin-3-gallate enhances ER stress-induced cancer cell apoptosis by directly targeting PARP16 activity［J］.Cell Death Discovery,2017,3:17034.
[22] Moradzadeh M,Hosseini A,Erfanian S,et al.Epigallocatechin-3-gallate promotes apoptosis in human breast cancer T47D cells through down-regulation of PI3K/AKT and Telomerase［J］.Pharmacological Reports,2017,69(5):924-928.
[23] Huang CY,Han Z,Li X,et al.Mechanism of EGCG promoting apoptosis of MCF-7 cell line in human breast cancer［J］.Oncology Letters,2017,14(3):3623-3627.
[24] Zhou CG,Hui LM,Luo JM,et al.Epigallocatechin gallate inhibits the proliferation and induces apoptosis of multiple myeloma cells via inactivating EZH2［J］.Eur Rev Med Pharmacol Sci,2018,22(7):2093-2098.
[25] Kantono M,Guo B.Inflammasomes and cancer:The dynamic role of the inflammasome in tumor development［J］.Frontiers in Immunology,2017,8:1132.
[26] Xie H,Sun J,Chen Y,et al.EGCG attenuates uric acid-induced inflammatory and oxidative stress responses by medicating the NOTCH pathway［J］.Oxidative Medicine and Cellular Longevity,2015,2015(1):1-10.
[27] Liu D,Perkins JT,Hennig B.EGCG prevents PCB-126-induced endothelial cell inflammation via epigenetic modifications of NF-κB target genes in human endothelial cells［J］.Journal of Nutritional Biochemistry,2016,28:164.
[28] Liu W,Dong M,Bo L,et al.Epigallocatechin-3-gallate ameliorates seawater aspiration-induced acute lung injury via regulating inflammatory cytokines and inhibiting JAK/STAT1 pathway in rats［J］.Mediators Inflamm,2015,2014(7):612593.
[29] Mukherjee S,Siddiqui MA,Dayal S,et al.Epigallocatechin-3-gallate suppresses proinflammatory cytokines and chemokines induced by Toll-like receptor 9 agonists in prostate cancer cells［J］.Journal of Inflammation Research,2014,7:89-101.
[30] Rashidi B,Malekzadeh M,Goodarzi M,et al.Green tea and its anti-angiogenesis effects［J］.Biomedicine & Pharmacotherapy,2017,89:949-956.
[31] Jin G,Yang Y,Liu K,et al.Combination curcumin and (-)-epigallocatechin-3-gallate inhibits colorectal carcinoma microenvironment-induced angiogenesis by JAK/STAT3/IL-8 pathway［J］.Oncogenesis,2017,6(10):e384.
[32] Shi J,Liu F,Zhang W,et al.Epigallocatechin-3-gallate inhibits nicotine-induced migration and invasion by the suppression of angiogenesis and epithelial-mesenchymal transition in non-small cell lung cancer cells［J］.Oncology Reports,2015,33(6):2972.
[33] Wang J,Man G,Chan TH,et al.A prodrug of green tea polyphenol (-)-epigallocatechin-3-gallate (Pro-EGCG) serves as a novel angiogenesis inhibitor in endometrial cancer［J］.Cancer Letters,2018,412:10-20.
[34] Sakamoto Y,Terashita N,Muraguchi T,et al.Effects of epigallocatechin-3-gallate (EGCG) on A549 lung cancer tumor growth and angiogenesis［J］.Journal of the Agricultural Chemical Society of Japan,2013,77(9):1799-1803.
[35] Hashimoto O,Nakamura A,Nakamura T,et al.Methylated-(3'')-epigallocatechin gallate analog suppresses tumor growth in Huh7 hepatoma cells via inhibition of angiogenesis［J］.Nutrition & Cancer,2014,66(4):728-735.
[36] Luo KW,Chen W,Lung WY,et al.EGCG inhibited bladder cancer SW780 cell proliferation and migration both in vitro and in vivo via down-regulation of NF-κB and MMP-9［J］.Journal of Nutritional Biochemistry,2017,41:56-64.
[37] Zhou F,Zhou H,Wang T,et al.Epigallocatechin-3-gallate inhibits proliferation and migration of human colon cancer SW620 cells in vitro［J］.Acta Pharmacol Sin,2012,3(1):120-126.
[38] Farabegoli F,Govoni M,Spisni E,et al.EGFR inhibition by (-)-epigallocatechin-3-gallate and IIF treatments reduces breast cancer cell invasion［J］.Bioscience Reports,2017,37(3):BSR20170168.
[39] Li YJ,Wu SL,Lu SM,et al.(-)-Epigallocatechin-3-gallate inhibits nasopharyngeal cancer stem cell self-renewal and migration and reverses the epithelial-mesenchymal transition via NF-κB p65 inactivation［J］.Tumour Biology,2015,36(4):2747.